BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34843882)

  • 1. Risk assessment of the inhibition of hydroxygenkwanin on human and rat cytochrome P450 by cocktail method.
    Gao J; Zhang Y; Lei X; Xu Y; Sun Z; Wang X
    Toxicol In Vitro; 2022 Mar; 79():105281. PubMed ID: 34843882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of cytochrome P450 inhibitory properties of deoxyshikonin, a bioactive compound from Lithospermum erythrorhizon Sieb. et Zucc.
    Zhang Y; Gao J; Xu Y; Liu J; Huang S; Li G; Yao B; Sun Z; Wang X
    Phytother Res; 2022 Nov; ():. PubMed ID: 36317387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
    Wang B; Yang S; Hu J; Li Y
    J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats.
    Xu RA; Xu ZS; Ge RS
    J Ethnopharmacol; 2014 Feb; 151(3):1141-1146. PubMed ID: 24373810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.
    Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay.
    Tang S; Chen A; Zhou X; Zeng L; Liu M; Wang X
    Toxicol Lett; 2017 Nov; 281():74-83. PubMed ID: 28941798
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
    Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
    Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes
    Wang J; Chen F; Jiang H; Xu J; Meng D; Geng P; Dai D; Hu J; Zhou Y; Zhou Q; Wang S
    Front Pharmacol; 2020; 11():593518. PubMed ID: 33746741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity.
    Sun M; Tang Y; Ding T; Liu M; Wang X
    Fitoterapia; 2014 Jan; 92():1-8. PubMed ID: 24144799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration with simvastatin or lovastatin alters the pharmacokinetic profile of sinomenine in rats through cytochrome P450-mediated pathways.
    Wang Y; Jin Y; Yun X; Wang M; Dai Y; Xia Y
    Life Sci; 2018 Sep; 209():228-235. PubMed ID: 30096386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro Inhibitory Effects of Cynaroside on Human Liver Cytochrome P450 Enzymes.
    Wang L; Ma X; Wang J; Li C
    Pharmacology; 2019; 104(5-6):296-302. PubMed ID: 31587003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4'-hydroxylation: A comparison with ABT for drug ADME optimization and mechanism study.
    Li Z; Zhang Y; Gao Y; Xiang Y; Zhang W; Lu C; Zhuang X
    Eur J Pharm Sci; 2019 Mar; 130():156-165. PubMed ID: 30690186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of cytochrome P450 inhibitory properties of maslinic acid, a bioactive compound from Olea europaea L., and its structure-activity relationship.
    Sun M; Tang Y; Ding T; Liu M; Wang X
    Phytomedicine; 2015 Jan; 22(1):56-65. PubMed ID: 25636872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of notoginseng total saponins (NS), safflower total flavonoids (SF), and the combination of NS and SF (CNS) on the activities of cytochrome P450 enzymes using a cocktail method in rats.
    Li Y; Lu YY; Meng YQ; Du ZY; Gao P; Zhao MB; Jiang Y; Tu PF; Guo XY
    Biomed Chromatogr; 2021 Oct; 35(10):e5171. PubMed ID: 34010455
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Li Y; Qin J; Wu H; Xu Y; Zhang L; Su K; Cui Y; Wang H
    Pharm Biol; 2020 Dec; 58(1):695-700. PubMed ID: 32673137
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Li J; Wen H; Gao Z
    Xenobiotica; 2020 Feb; 50(2):231-236. PubMed ID: 31020909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS.
    Otten JN; Hingorani GP; Hartley DP; Kragerud SD; Franklin RB
    Drug Metab Lett; 2011 Jan; 5(1):17-24. PubMed ID: 21198441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.